Insights

Strategic Alignment Leverage the integration with Lantheus, a leading radiopharmaceutical company, to position solutions that support radiology imaging, clinical data management, and regulatory-compliant workflows across the combined organization.

Financial Growth Target cross-sell opportunities around imaging radiopharmaceuticals and related services as Lantheus demonstrates multi-hundred-million-dollar revenue streams, signaling expanding demand for advanced analytics, manufacturing optimization, and commercial enablement tools.

Expansion Prospects Capitalize on SNMMI and ASCO conference activity and ongoing radiopharmaceutical launches to offer clinical data platforms, education, and engagement tooling that can support market uptake and KOL outreach in nuclear imaging.

Technical Synergy Propose solutions that complement Lantheus’ tech stack (Databricks, Jira, Drupal, Terraform, Shopify, Adobe) to improve data science workflows, project management, content management, and customer engagement across research, manufacturing, and sales.

Strategic Partners Position offerings to CMIT and BRF collaborations and manufacturing partnerships as a pathway for scalable deployment of radiopharmaceutical production and digital tooling, enabling faster time-to-market and broader geographic reach.

Similar companies to Progenics Pharmaceuticals, Inc.

Progenics Pharmaceuticals, Inc. Tech Stack

Progenics Pharmaceuticals, Inc. uses 8 technology products and services including Linkedin Insight Tag, Databricks, AutoCAD, and more. Explore Progenics Pharmaceuticals, Inc.'s tech stack below.

Media & News

Progenics Pharmaceuticals, Inc.'s Email Address Formats

Progenics Pharmaceuticals, Inc. uses at least 8 email formats:
Progenics Pharmaceuticals, Inc. Email FormatsExamplePercentage
First.Last@lantheus.comJohn.Doe@lantheus.com
85%
First.L@lantheus.comJohn.D@lantheus.com
9%
LastF@lantheus.comDoeJ@lantheus.com
5%
Last.First@lantheus.comDoe.John@lantheus.com
1%
FLast@progenics.comJDoe@progenics.com
85%
FiLast@progenics.comJoDoe@progenics.com
9%
FirLast@progenics.comJohDoe@progenics.com
4%
FirstLast@progenics.comJohnDoe@progenics.com
2%

Frequently Asked Questions

What is Progenics Pharmaceuticals, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Progenics Pharmaceuticals, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Progenics Pharmaceuticals, Inc.'s stock symbol?

Minus sign iconPlus sign icon
Progenics Pharmaceuticals, Inc. is a publicly traded company; the company's stock symbol is PGNX.

What is Progenics Pharmaceuticals, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Progenics Pharmaceuticals, Inc.'s official website is lantheus.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Progenics Pharmaceuticals, Inc. generate?

Minus sign iconPlus sign icon
As of August 2026, Progenics Pharmaceuticals, Inc.'s annual revenue is estimated to be $25M - $50M.

What is Progenics Pharmaceuticals, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Progenics Pharmaceuticals, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Progenics Pharmaceuticals, Inc. have currently?

Minus sign iconPlus sign icon
As of August 2026, Progenics Pharmaceuticals, Inc. has approximately 47 employees across 3 continents, including North America, Africa and Europe. Key team members include Head Finance And Administration: M. M., Associate Director, Marketing: A. F. and Director Global Pharmacovigilance Case Management: L. K. Explore Progenics Pharmaceuticals, Inc.'s employee directory with LeadIQ.

What industry does Progenics Pharmaceuticals, Inc. belong to?

Minus sign iconPlus sign icon
Progenics Pharmaceuticals, Inc. operates in the Biotechnology Research industry.

What technology does Progenics Pharmaceuticals, Inc. use?

Minus sign iconPlus sign icon
Progenics Pharmaceuticals, Inc.'s tech stack includes Linkedin Insight Tag, Databricks, AutoCAD, HashiCorp Terraform, Drupal, Shopify, Atlassian Jira and Adobe Creative Suite.

What is Progenics Pharmaceuticals, Inc.'s email format?

Minus sign iconPlus sign icon
Progenics Pharmaceuticals, Inc.'s email format typically follows the pattern of First.Last@lantheus.com. Find more Progenics Pharmaceuticals, Inc. email formats with LeadIQ.

How much funding has Progenics Pharmaceuticals, Inc. raised to date?

Minus sign iconPlus sign icon
As of August 2026, Progenics Pharmaceuticals, Inc. has raised $75M in funding. The last funding round occurred on Aug 01, 2018 for $75M.

When was Progenics Pharmaceuticals, Inc. founded?

Minus sign iconPlus sign icon
Progenics Pharmaceuticals, Inc. was founded in 1988.
Progenics Pharmaceuticals, Inc. logo

Progenics Pharmaceuticals, Inc.

Biotechnology ResearchNew York, United States11-50 Employees

Progenics Pharmaceuticals, Inc. is a biotechnology research company that has been integrated into Lantheus. It is based in New York, operating as part of the Lantheus organization. The arrangement places Progenics in the context of a broader radiopharmaceutical and medical imaging field. Lantheus is described as a radiopharmaceutical-focused company, and the provided news items show active engagement in major imaging and oncology conferences. The current information notes that Progenics is now a Lantheus company, marking a formal linkage within a larger corporate structure.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
PGNX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1988
Employees
11-50

Section iconFunding & Financials

  • $75M

    Progenics Pharmaceuticals, Inc. has raised a total of $75M of funding over 1 rounds. Their latest funding round was raised on Aug 01, 2018 in the amount of $75M as a Post IPO Equity.

  • $25M - $50M

    Progenics Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.